当前位置: 首页 >> 检索结果
共有 3894 条符合本次的查询结果, 用时 3.8540073 秒

3521. Heart failure and abnormal ventricular function. Pathophysiology and clinical correlation (Part 1).

作者: C Shub.
来源: Chest. 1989年96卷3期636-40页

3522. Dyspnea in pregnancy.

作者: M F Tenholder.;J E South-Paul.
来源: Chest. 1989年96卷2期381-8页

3523. Calcium channel blockers as inhibitors of drug metabolism.

作者: B A Hunt.;T H Self.;R L Lalonde.;M B Bottorff.
来源: Chest. 1989年96卷2期393-9页

3524. Nutritional support in the critical care setting (Part 2).

作者: R Berger.;L Adams.
来源: Chest. 1989年96卷2期372-80页

3525. Therapeutic approach to malignant mesothelioma.

作者: J Aisner.
来源: Chest. 1989年96卷1 Suppl期95S-97S页

3526. Diet and lung cancer.

作者: A B Miller.;H A Risch.
来源: Chest. 1989年96卷1 Suppl期8S-9S页

3527. Preoperative assessment of lung cancer.

作者: P Drings.
来源: Chest. 1989年96卷1 Suppl期42S-44S页

3528. Autocrine growth factors as therapeutic targets in lung cancer.

作者: J L Mulshine.;A M Treston.;R B Natale.;P G Kasprzyk.;I Avis.;Y Nakanishi.;F Cuttitta.
来源: Chest. 1989年96卷1 Suppl期31S-34S页

3529. Molecular mechanisms in chemically induced cancer.

作者: P J O'Connor.
来源: Chest. 1989年96卷1 Suppl期24S-25S页

3530. Genetic events in the pathogenesis of lung cancer.

作者: J D Minna.
来源: Chest. 1989年96卷1 Suppl期17S-23S页

3531. Chemoprevention of lung cancer. Problems and progress.

作者: P Greenwald.;J W Cullen.;G Kelloff.;H F Pierson.
来源: Chest. 1989年96卷1 Suppl期14S-17S页

3532. Problems in assessing quality of life (QL) of lung cancer patients in clinical trials.

作者: C Hürny.;J Bernhard.
来源: Chest. 1989年96卷1 Suppl期102S-105S页

3533. Lung cancer--a worldwide health problem.

作者: K Stanley.;J Stjernswärd.
来源: Chest. 1989年96卷1 Suppl期1S-5S页

3534. Medical indications for tracheotomy.

作者: J E Heffner.
来源: Chest. 1989年96卷1期186-90页

3535. Mechanisms of laryngotracheal injury following prolonged tracheal intubation.

作者: M J Bishop.
来源: Chest. 1989年96卷1期185-6页

3536. Physiologic implications of artificial airways.

作者: M P Habib.
来源: Chest. 1989年96卷1期180-4页

3537. Influence of the extracellular matrix on type 2 cell differentiation.

作者: D E Rannels.;S R Rannels.
来源: Chest. 1989年96卷1期165-73页
Growth and division of type II pulmonary epithelial cells are important components of the pathway by which the alveolar surface is repaired following several forms of lung injury. These processes, which result in reepithelialization of the denuded alveolar basement membrane, involve loss of type II cell differentiation and transition to a type I epithelium. As in other cells, the extracellular matrix appears to be an important determinant of type II cell differentiation. This effect on the type II cell is exerted by both simple and complex matrices and may be modulated by active synthesis and remodeling of the matrix components by the pneumocytes themselves. In general, laminin or laminin-rich complex surfaces favor cellular differentiation; fibronectin or fibronectin-rich complex matrices accelerate loss of differentiated form and function. In both cases, matrix-initiated changes in the type II cell involve regulation of cell shape and morphology, hormone responsiveness, secretory activity, phospholipid synthesis, protein turnover, and gene expression. These influences of the extracellular matrix, along with the effects of locally acting soluble factors, likely direct the cellular transitions required for restoration of a physiologically competent alveolar surface during the repair of lung injury.

3538. The epidemiology and pathogenesis of malignant mesothelioma.

作者: J E Craighead.
来源: Chest. 1989年96卷1 Suppl期92S-93S页

3539. Adjuvant therapy for non-small cell lung cancer.

作者: W K Evans.
来源: Chest. 1989年96卷1 Suppl期87S-91S页

3540. Radiotherapy in non-small cell lung cancer. An overview.

作者: M Tubiana.
来源: Chest. 1989年96卷1 Suppl期85S-87S页
共有 3894 条符合本次的查询结果, 用时 3.8540073 秒